| TTM
|
12/31/2025
|
12/31/2024
|
12/31/2023
|
12/31/2022
|
|
|---|---|---|---|---|---|
| Total Revenue
|
22,493,690 | 21,513,071 | 22,066,604 | 23,560,347 | 24,676,960 |
| Cost of Revenue
|
-19,408,425 | -18,621,054 | -19,315,230 | -21,035,103 | -22,273,195 |
|
Gross Profit
|
3,085,265 | 2,892,017 | 2,751,374 | 2,525,244 | 2,403,765 |
| Selling, General and Administrative Expenses
|
-1,236,932 | -1,189,647 | -1,110,220 | -991,284 | -918,895 |
|
Research and Development Expenses
|
-9,808 | -9,409 | -9,664 | -9,315 | -9,435 |
|
Operating Income/Expenses
|
-1,246,740 | -1,199,056 | -1,119,884 | -1,000,599 | -928,330 |
|
Total Operating Profit/Loss
|
1,838,525 | 1,692,961 | 1,631,490 | 1,524,645 | 1,475,435 |
| Total Net Finance Income/Expense
|
1,598 | -1,795 | -4,652 | -1,628 | -3,779 |
| Irregular Income/Expenses
|
-4,377 | -3,221 | -1,872 | -3,142 | -1,382 |
|
Other Income/Expense, Non-Operating
|
52,006 | 43,293 | 86,400 | 53,718 | 126,068 |
|
Non-Operating Income/Expenses, Total
|
49,227 | 38,277 | 79,876 | 48,948 | 120,907 |
|
Pretax Income
|
1,887,752 | 1,731,238 | 1,711,366 | 1,573,593 | 1,596,342 |
|
Provision for Income Tax
|
-374,307 | -349,536 | -338,852 | -319,852 | -328,543 |
|
Net Income from Continuing Operations
|
1,513,445 | 1,381,702 | 1,372,514 | 1,253,741 | 1,267,799 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
1,513,445 | 1,381,702 | 1,372,514 | 1,253,741 | 1,267,799 |
|
Non-Controlling/Minority Interests
|
-68,487 | -61,212 | -55,097 | -48,890 | -41,594 |
|
Net Income after Non-Controlling/Minority Interests
|
1,444,958 | 1,320,490 | 1,317,417 | 1,204,851 | 1,226,205 |
|
Net Income Available to Common Stockholders
|
1,444,958 | 1,320,490 | 1,317,417 | 1,204,851 | 1,226,205 |
|
Diluted Net Income Available to Common Stockholders
|
1,444,958 | 1,320,490 | 1,317,417 | 1,204,851 | 1,226,205 |
| Basic EPS
|
9.03 | 8.25 | 8.24 | 7.53 | 7.66 |
| Diluted EPS
|
9.01 | 8.24 | 8.22 | 7.52 | 7.65 |
|
Basic Weighted Average Shares Outstanding
|
160,026.76 | 160,059.39 | 159,880.70 | 160,006.77 | 160,078.98 |
|
Diluted Weighted Average Shares Outstanding
|
160,391.12 | 160,253.64 | 160,269.71 | 160,219.55 | 160,288.24 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
1,886,154 | 1,733,033 | 1,716,018 | 1,575,221 | 1,600,121 |
|
EBITDA
|
2,177,257 | 2,027,719 | 2,002,550 | 1,811,727 | 1,811,152 |
|
Normalized EBITDA
|
2,177,344 | 2,029,029 | 1,995,653 | 1,824,119 | 1,812,560 |
|
Normalized Income
|
1,513,514.75 | 1,382,747.51 | 1,366,982.61 | 1,263,614.18 | 1,268,917.22 |
|
Total Unusual Items
|
87 | 1,310 | -6,897 | 12,392 | 1,408 |
|
Total Unusual Items Excluding Goodwill
|
87 | 1,310 | -6,897 | 12,392 | 1,408 |
12/31/2022 - 1/4/2000
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade